Women seeking treatment for substance use disorders often have clinical and practical needs that differ from men, and these differences can influence assessment, placement, and services offered. This article reviews evidence-informed treatment considerations for women, highlights high-risk situations that require urgent care, and offers practical guidance for patients and families. Placement and medication decisions require evaluation by a qualified clinician. Call 911 for a medical emergency and call or text 988 for a mental health or suicide crisis.

Why gender matters in addiction care

Sex, gender, and social roles affect how substance use begins, how quickly problems progress, and which co-occurring conditions are common. Women with substance use disorders are more likely than men to have co-occurring mood, anxiety, or posttraumatic stress disorders, and they often report histories of physical or sexual trauma. Treatment that recognizes these patterns and offers integrated mental health care and trauma-informed practices is associated with better engagement and retention in care. (nida.nih.gov)

Common clinical and social needs

  • High rates of trauma exposure and posttraumatic stress symptoms, which can be triggered in treatment without trauma-aware care. (samhsa.gov)
  • Greater likelihood of co-occurring depression and anxiety, which need concurrent assessment and treatment. (nida.nih.gov)
  • Childcare responsibilities and legal or custody concerns, which create practical barriers to attending appointments. (pubmed.ncbi.nlm.nih.gov)
  • Pregnancy and postpartum needs that require specialized guidance about medications and obstetric coordination. (cdc.gov)
  • Stigma and fear of punitive consequences, which can deter help-seeking and shape disclosure. (pubmed.ncbi.nlm.nih.gov)

Clinical approaches and evidence-based principles

Clinical guidance for women emphasizes gender-responsive and trauma-informed care, integrated behavioral health, and, when appropriate, medication for substance use disorders. The Substance Abuse and Mental Health Services Administration TIP 51 and related SAMHSA guidance outline program design features that improve access and outcomes for women. (samhsa.gov)

Medication and pregnancy

For opioid use disorder in pregnancy, major public health and professional bodies recommend medication for opioid use disorder such as buprenorphine or methadone rather than supervised withdrawal, because medication-based therapy reduces the risk of relapse and harms to the fetus and mother. Decisions about continuing or changing medication should be made by the patient and clinicians together, with prenatal care coordination and pediatric planning for the newborn. Rapid opioid tapering in pregnancy is not routinely recommended. (cdc.gov)

When pregnancy, breastfeeding, adolescents, severe withdrawal, seizures, psychosis, or overdose are present, urgent or specialized medical care is required. These situations are high risk and need clinicians with appropriate expertise. Call 911 in a life threatening emergency. (cdc.gov)

Treatment settings and how needs shape placement

Choosing a setting depends on medical severity, withdrawal risk, pregnancy status, co-occurring psychiatric conditions, social supports, and practical needs like childcare and transportation. Below is a concise comparison to help patients and families discuss options with clinicians.

Setting Who it may suit Key clinical needs addressed Typical services
Outpatient medication-based treatment Medically stable adults, including pregnant women needing MOUD Medication management, counseling, prenatal coordination Buprenorphine or methadone programs, counseling, case management
Outpatient detox with medical supervision Lower-severity dependence without major medical risks Symptom management, referral to ongoing care Medical monitoring, brief behavioral therapy, follow-up planning
Residential treatment High psychosocial instability, lack of safe home, intensive needs Structure, medication continuation, trauma-informed therapy Multidisciplinary care, parenting supports, group therapy
Women-only or gender-responsive programs Women who prefer single-gender care or need parenting supports Address trauma, childcare, family and reproductive health Integrated behavioral health, case management, peer support

These categories are not exclusive and many programs combine elements to meet complex needs. Treatment choice should follow a clinical assessment by a qualified clinician and consider patient preferences, pregnancy status, and local resources. (samhsa.gov)

Practical strategies to improve access and retention

  • Offer flexible scheduling, telehealth options, and childcare supports where possible, to reduce structural barriers. Evidence reviews highlight childcare and scheduling as major determinants of treatment entry and retention for mothers. (pubmed.ncbi.nlm.nih.gov)
  • Use patient navigation or care coordination for pregnant and postpartum people, to connect prenatal care, addiction treatment, and pediatric follow-up. Systematic reviews show patient navigation can reduce fragmentation and improve engagement. (pubmed.ncbi.nlm.nih.gov)
  • Implement trauma-informed practices across staff training, intake procedures, and treatment planning to reduce re-traumatization and support safety. (samhsa.gov)
  • Provide integrated screening and treatment for mood and anxiety disorders, because co-occurring mental health conditions are common among women with substance use disorders. (nida.nih.gov)

Safety callout

Immediate safety guidance

If you or someone else is experiencing severe withdrawal, seizures, hallucinations, suicidal thoughts, uncontrollable vomiting, signs of overdose, or any life threatening symptom, call 911 now. For a mental health or suicide crisis, call or text 988. For urgent concerns about medication in pregnancy or an overdose, contact emergency services and notify your treatment team immediately.  (cdc.gov)

Frequently asked questions

Are there treatments specifically for women?

Yes. Gender-responsive programs adapt services to address common needs of women, such as trauma-informed therapy, parenting supports, reproductive health, and childcare. These services aim to reduce barriers and improve engagement, but choice should depend on individual needs and clinical assessment. (samhsa.gov)

Can pregnant women receive medication for opioid use disorder?

Yes. Methadone and buprenorphine are recommended as first-line medications for opioid use disorder during pregnancy, in combination with counseling and coordinated obstetric care. Rapid opioid withdrawal is generally not recommended during pregnancy because of risks to the fetus. Medication decisions should be made with obstetric and addiction specialists. (cdc.gov)

What about breastfeeding while on MOUD?

When appropriate and after clinical evaluation, breastfeeding is often supported for women who are stable on buprenorphine or methadone and who are not using nonprescribed substances. Pediatric follow-up and lactation support should be planned. (cdc.gov)

How do programs handle child custody or mandated reporting?

Programs must follow state laws on child welfare and reporting. Some jurisdictions emphasize nonpunitive, health-first approaches for pregnant and parenting people. In New Jersey, health guidance stresses universal screening and informed consent for follow-up testing, and clarifies that a positive screen alone is not necessarily evidence of child abuse. Discuss legal concerns with your treatment team and, if needed, social work or legal aid. (nj.gov)

Next steps and resources

This information is general educational material and not a substitute for professional assessment. Placement and medication choices require a clinical evaluation by providers experienced in addiction medicine and, when relevant, obstetrics. If you are exploring care in New Jersey, your local health department guidance and treatment locator resources can help find programs that address women-specific needs. For program information and to request a confidential assessment, consider reviewing available services and contacting admissions teams for confidential guidance.

Helpful links:

Sources

If you would like a confidential discussion about whether a particular program or medication approach is appropriate, please request a confidential assessment or speak with an admissions team member through the contact page above. We do not promise admission, coverage, or outcomes. Clinical decisions should be made with qualified clinicians who can assess medical and psychosocial needs.